FMP
NASDAQ
21.32 USD
-0.08 (-0.375%)
Mr. Paul J. Diaz
Healthcare
Diagnostics & Research
https://myriad.com
NASDAQ
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing the risks for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic Test, a DNA sequencing test to help determine the therapy for patients with metastatic breast, ovarian, metastatic pancreatic, or metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic Test, a tum...
0000899923
US62855J1043
62855J104
320 Wakara Way
801 584 3600
US
2,700
Oct 6, 1995
0000899923
NASDAQ
Diagnostics & Resear...
Healthcare
62855J104
US62855J1043
US
21.32
1.96
645.89k
1.92B
-
13.82-24.21
-2.65
-
-
-
-
-6.7
-
https://myriad.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.